Heather Feigelson to Hormone Replacement Therapy
This is a "connection" page, showing publications Heather Feigelson has written about Hormone Replacement Therapy.
Connection Strength
0.692
-
Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 2004 Feb; 13(2):220-4.
Score: 0.238
-
Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy. Cancer Res. 1999 Aug 15; 59(16):3908-10.
Score: 0.175
-
Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen. Int J Cancer. 2010 Dec 15; 127(12):2928-35.
Score: 0.096
-
Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev. 2008 Jan; 17(1):73-9.
Score: 0.078
-
Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women. Cancer. 2006 Jul 01; 107(1):12-21.
Score: 0.070
-
Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium. Breast Cancer Res Treat. 2016 Feb; 155(3):531-40.
Score: 0.034